Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8979
|
| pubmed:dateCreated |
1995-10-27
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0140-6736
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
30
|
| pubmed:volume |
346
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
908-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:7564704-Antipsychotic Agents,
pubmed-meshheading:7564704-Clozapine,
pubmed-meshheading:7564704-Humans,
pubmed-meshheading:7564704-Mutation,
pubmed-meshheading:7564704-Receptor, Serotonin, 5-HT2A,
pubmed-meshheading:7564704-Receptors, Serotonin,
pubmed-meshheading:7564704-Schizophrenia
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Genetic variation of the 5-HT2A receptor and response to clozapine.
|
| pubmed:publicationType |
Letter,
Comment,
Research Support, Non-U.S. Gov't
|